Moderna’s Bid For Second COVID Vaccine Booster Spans Broader Age Group Than Pfizer/BioNTech

 
• By Sue Sutter
Paint brushes
Moderna is using broad brush strokes in its bid for authorization of a second booster dose, compared to Pfizer/BioNTech's narrower request. • Source: Alamy

More from Vaccines

More from Pink Sheet